Mobileye Global Inc
NASDAQ:MBLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mobileye Global Inc
NASDAQ:MBLY
|
IL |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
CN |
|
Bowlero Corp
NYSE:BOWL
|
US |
|
P
|
Protektor SA
WSE:PRT
|
PL |
Balance Sheet
Balance Sheet Decomposition
Mobileye Global Inc
Mobileye Global Inc
Balance Sheet
Mobileye Global Inc
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
85
|
616
|
1 024
|
1 154
|
1 370
|
1 836
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
35
|
|
| Cash Equivalents |
85
|
616
|
1 024
|
1 154
|
1 370
|
1 801
|
|
| Short-Term Investments |
0
|
0
|
0
|
222
|
419
|
785
|
|
| Total Receivables |
1 425
|
1 481
|
269
|
357
|
212
|
131
|
|
| Accounts Receivables |
93
|
155
|
269
|
357
|
212
|
131
|
|
| Other Receivables |
1 332
|
1 326
|
0
|
0
|
0
|
0
|
|
| Inventory |
128
|
97
|
113
|
391
|
415
|
327
|
|
| Other Current Assets |
54
|
76
|
110
|
106
|
121
|
184
|
|
| Total Current Assets |
1 692
|
2 270
|
1 516
|
2 066
|
2 174
|
2 478
|
|
| PP&E Net |
213
|
325
|
441
|
496
|
505
|
523
|
|
| PP&E Gross |
213
|
325
|
441
|
496
|
505
|
523
|
|
| Accumulated Depreciation |
44
|
58
|
81
|
97
|
128
|
171
|
|
| Intangible Assets |
3 580
|
3 071
|
2 527
|
2 053
|
1 609
|
1 166
|
|
| Goodwill |
10 895
|
10 895
|
10 895
|
10 895
|
8 200
|
8 200
|
|
| Other Long-Term Assets |
82
|
94
|
62
|
67
|
91
|
125
|
|
| Other Assets |
10 895
|
10 895
|
10 895
|
10 895
|
8 200
|
8 200
|
|
| Total Assets |
16 462
N/A
|
16 655
+1%
|
15 441
-7%
|
15 577
+1%
|
12 579
-19%
|
12 492
-1%
|
|
| Liabilities | |||||||
| Accounts Payable |
109
|
160
|
189
|
229
|
190
|
228
|
|
| Accrued Liabilities |
91
|
114
|
101
|
99
|
118
|
159
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
110
|
200
|
94
|
75
|
25
|
19
|
|
| Total Current Liabilities |
310
|
474
|
384
|
403
|
333
|
406
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
208
|
181
|
162
|
148
|
47
|
60
|
|
| Other Liabilities |
102
|
111
|
101
|
102
|
112
|
145
|
|
| Total Liabilities |
620
N/A
|
766
+24%
|
647
-16%
|
653
+1%
|
492
-25%
|
611
+24%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
9
|
8
|
8
|
8
|
|
| Retained Earnings |
15 842
|
15 884
|
57
|
30
|
3 060
|
3 452
|
|
| Additional Paid In Capital |
0
|
0
|
14 737
|
14 886
|
15 137
|
15 308
|
|
| Other Equity |
0
|
5
|
9
|
0
|
2
|
17
|
|
| Total Equity |
15 842
N/A
|
15 889
+0%
|
14 794
-7%
|
14 924
+1%
|
12 087
-19%
|
11 881
-2%
|
|
| Total Liabilities & Equity |
16 462
N/A
|
16 655
+1%
|
15 441
-7%
|
15 577
+1%
|
12 579
-19%
|
12 492
-1%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
796
|
796
|
802
|
806
|
812
|
815
|
|